PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Breast Cancer Screening Decision Aid
- Registration Number
- NCT01879189
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System.
- Detailed Description
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool incorporates questions about a women's personal history of breast cancer and compares her to the average women her age in terms of breast cancer risk. The tool helps the women to understand the benefits and risks of breast cancer screening. This tool will be pilot tested using SSI to help develop the final version of the decision aid tool. The decision aid tool will then be implemented and tested in nine general internal medicine, family medicine, and OB/GYN practices within the University of Pennsylvania Health System.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1302
- Women ages 39-48
- Patient of one of the nine primary care or OB/GYN practices that are participating in the study
- Must have had an appointment at one of these locations in the past 24 months
- Must have an appointment during the study period
- Woman has not yet initiated breast cancer screening (no prior mammogram)
- No history of breast cancer
- Prior diagnosis of breast cancer
- Major comorbidity that substantially affects their 10 year mortality
- Non-English speaker
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Decision Aid Breast Cancer Screening Decision Aid Those in the decision aid arm of the study will be given access to the breast cancer screening decision aid.
- Primary Outcome Measures
Name Time Method Mammography Use Correlated to Personal Risk of Breast Cancer One year post-intervention Medical charts of women in both the intervention and control groups of the study will be analyzed to determine if these women initiated breast cancer screening (mammography) correlated to their personal risk of breast cancer as displayed by the decision aid.
- Secondary Outcome Measures
Name Time Method Knowledge, Worry, Regret, Decisional Conflict, Accuracy of Risk Perception 6 weeks post-intervention Six weeks after a women's appointment with their primary care or OB/GYN provider, they will receive a post-intervention survey which will assess knowledge, worry, satisfaction, numeracy, behavior, etc.
Trial Locations
- Locations (9)
Edward S. Cooper Internal Medicine
🇺🇸Philadelphia, Pennsylvania, United States
Family Medicine St. Leonard's Court
🇺🇸Philadelphia, Pennsylvania, United States
Family Medicine
🇺🇸Philadelphia, Pennsylvania, United States
Helen O. Dickens Center for Women's Health
🇺🇸Philadelphia, Pennsylvania, United States
Penn Center for Primary Care
🇺🇸Philadelphia, Pennsylvania, United States
Penn Internal Medicine Associates
🇺🇸Philadelphia, Pennsylvania, United States
Penn OB/GYN Associates
🇺🇸Philadelphia, Pennsylvania, United States
Internal Medicine Radnor
🇺🇸Radnor, Pennsylvania, United States
Penn Health for Women
🇺🇸Radnor, Pennsylvania, United States